Category: Hematology & Oncology
Oceania Hematology & Oncology
-
Immuno-Oncology Assays Market, By Product (Consumables and Software), By Technology (Immunoassay, PCR, NGS, Flow Cytometry, and Others), By Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, and Others), By Application (Clinical Diagnostics and Research and Development), and By Region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Development), and By Region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Immuno-oncology is emerging as a novel approach to cancer treatment through ... Read More
-
Global Immunoassays Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type (Reagents & Kits, Analyzers/Instruments, and Software & Services), Application (Cardiology, Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Technology (Radio immunoassay (RIA), Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions (North America, Asia Pacific, Europe, Latin America, Middle East and Africa)
... Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions ... Read More
-
Australia In-vitro Diagnostics Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)
... COVID, the country's conditions were under control. The administration kept its limitations on travel in place. The Australian Health Protection Principal Committee (AHPPC) highly advised wearing masks indoors, especially in situations where physical separation is ... Read More
-
2022 Asia-Pacific Hematology and Flow Cytometry Analyzer and Reagent Markets - Growth Opportunities in 18 Countries, Supplier Shares, Test Volume and Sales Segment Forecasts for over 40 Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Latest Technologies
... Strategies, Instrumentation Pipeline, Latest Technologies This new 18-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test, and can be customized to specific information needs and budget. The survey is designed ... Read More
-
2022 Australia Hematology and Flow Cytometry Analyzer and Reagent Markets - Supplier Shares, Test Volume and Sales Segment Forecasts for over 40 Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Latest Technologies
... from LeadingMarketResearch.com provides information and analysis not available from any other published source. Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging business ... Read More
-
2022 New Zealand Hematology and Flow Cytometry Analyzer and Reagent Markets - Supplier Shares, Test Volume and Sales Segment Forecasts for over 40 Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Latest Technologies
... report from LeadingMarketResearch.com provides information and analysis not available from any other published source. Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging ... Read More
-
2022-2026 New Zealand Cancer Diagnostics Market - Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing ... Read More
-
2022 What's Next for Asia-Pacific Hematology and Flow Cytometry Analyzer and Reagent Markets? - Growth Opportunities in 18 Countries, Supplier Shares, Test Volume and Sales Segment Forecasts—Competitive Strategies, Instrumentation Pipeline, Latest Technologies
... report from LeadingMarketResearch.com is available by country, market segment, section, or individual test, and can be customized to specific information needs and budget. The survey is designed to help current suppliers and potential market entrants ... Read More
-
In Vitro Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity ... Read More
-
Oncology Drugs Market, by Drug Type (Cytotoxic Drugs (Alkylating Agents, Antimetabolites, and Others), Targeted Drugs (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), and Hormonal Drugs (Ovarian Function Blockers, Estrogen Production Blockers, and Estrogen’s Effect Blockers (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and ... Read More
-
Colorectal Cancer Screening Market, By Screening Tests (Stool-based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, and Other Screening Tests), By End User (Hospitals Independent Diagnostic Labs and Other End Users), and By Geography (North America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Colorectal cancer is a type of cancer that begins in the large intestine (colon). The ... Read More
-
Molecular Diagnostics Market, by Product Type (Reagents & Kits and Instruments), by Application (Oncology, Genetic Testing, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, and Others), by End User (Hospitals, Diagnostic Laboratories, Academic and Research Labs, and Other), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Research Labs, and Other), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Molecular diagnostics is used for detection in various ... Read More
-
Asia-Pacific Cancer Diagnostics Market, By Diagnostic Type (Lab Testing, Genetic Testing, Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and Others), By Technology (Platform Based, Instrument Based, Tumor Biomarker Tests), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Skin cancer, Others), By End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and Others), By Country, Competition Forecast & Opportunities, 2027
... Breast Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Skin cancer, Others), By End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and Others), By Country, Competition Forecast & Opportunities, 2027 Asia-Pacific cancer diagnostics market is expected ... Read More
-
2022-2026 New Zealand Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood ... Read More
-
2022-2026 Australia Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood Banking ... Read More
-
2022-2026 New Zealand Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2022-2026 Asia-Pacific Cancer Diagnostics Market Database for 18 Countries - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or ... Read More
-
2022-2026 Australia Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed ... Read More
-
2022-2026 New Zealand Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and ... Read More
-
2022-2026 Australia Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
2022-2026 Asia-Pacific Diagnostics Market Forecasts for 500 Tests in 18 Countries - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM - Competitive Strategies, Opportunities for Suppliers
... Strategies, Opportunities for Suppliers This new report from LeadingMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South ... Read More
-
Asia-Pacific Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
Research Assistance
